Is Wegovy Legal in the UK — and How Do You Get It Lawfully?

Step 1, The legal foundation: how Wegovy earned its UK licence

Wegovy received its MHRA marketing authorisation for weight management after the regulator reviewed the clinical trial programme, including the STEP 1 trial published in the New England Journal of Medicine, which recorded an average body-weight reduction of around 15% over 68 weeks at the 2.4 mg maintenance dose. That authorisation applies to adults with a BMI of 30 or above, or 27 and above where at least one weight-related condition (such as high blood pressure, high cholesterol or obstructive sleep apnoea) is present. The medicine is a GLP-1 receptor agonist: it acts on gut-hormone pathways to reduce appetite and slow gastric emptying. Its licence is for weight management alongside a reduced-calorie diet and increased physical activity. It carries a Black Triangle (▼) status, meaning the MHRA collects additional safety data while it is used in the broader population, entirely normal for a newer medicine, not a cause for alarm.

Crucially, MHRA authorisation does not make a medicine freely available. The same process that proves Wegovy safe enough to licence also determines that it must only be used under clinical supervision, hence the prescription-only classification.

Step 2, The prescription requirement and what it rules out

A Prescription-Only Medicine can only be supplied legally when a GPhC-registered prescriber has assessed the patient and issued a valid prescription. That assessment exists for good reasons: Wegovy is not suitable for everyone, and there are genuine contraindications and interactions a trained prescriber needs to check. Anyone selling semaglutide pens without that step is operating outside UK law, and the MHRA has made abundantly clear that enforcement is active. Buying Wegovy from social-media sellers, unlisted websites, or anyone who offers pens without a clinical consultation is not a grey area; the rules on who can sell semaglutide lawfully are unambiguous. The MHRA's public warning about fake weight-loss pens documented hospitalisations linked to counterfeit products, some of which contained insulin rather than semaglutide. That is the practical consequence of bypassing the prescription route, not just a regulatory technicality. If you have any doubt about a product or seller, you can report it at the MHRA Yellow Card scheme.

Worth checking: before using any online pharmacy, look it up on the GPhC register. A registered pharmacy will display its registration number clearly.

Step 3, What lawful routes to Wegovy look like in practice

There are two legitimate pathways. The NHS route runs through specialist weight management services under NICE guidance (TA875), which recommends semaglutide for a maximum of two years within a multidisciplinary service. Eligibility criteria are strict and waiting lists at many services are long. The private route (a regulated online pharmacy or clinic) cuts the waiting time but not the clinical rigour. A GPhC-registered prescriber still reviews your case before any prescription is issued. At our pharmacy, that review is carried out by a named GPhC-registered Independent Prescriber the same day you submit your consultation; a real clinician reads your answers, not software. Once approved and dispatched before 12pm, your treatment arrives the next working day by tracked DPD in plain packaging, straightforward from the moment clinical sign-off is confirmed.

For a broader picture of how the medicine works and what the treatment course involves, the Wegovy overview page covers the full detail, including the titration schedule and what the clinical trial results mean in practice. If cost is part of your thinking, the Wegovy cost page gives an honest account of what private treatment typically involves and what a legitimate price includes.

Step 4 (The common confusion: Ozempic, Rybelsus and the legal distinctions

Semaglutide exists under several brand names in the UK, and the legal status of each depends on its licensed indication) not the molecule. Ozempic is the same active ingredient but holds a licence for type 2 diabetes, not weight management. Prescribing it for weight loss is not a standard lawful route, and obtaining it that way from an unregulated source carries all the same counterfeiting risks. Rybelsus is oral semaglutide licensed for type 2 diabetes. Neither is an alternative to Wegovy for weight management. People sometimes ask whether semaglutide is illegal, and the answer depends entirely on the brand, the indication, and how it has been obtained, which the distinctions across all three brands explain in full. If you want to understand whether semaglutide is legal for your specific situation, that page sets out the framework clearly before you make any decisions. The newest development in the UK is the approval, in June 2026, of a once-daily Wegovy tablet (the first oral GLP-1 medicine licensed in the UK for weight management) which follows a different dosing path to the injection but sits within the same legal framework: prescription only, prescriber-assessed, GPhC-regulated supply. More on semaglutide in all its forms is available if you want the full picture before deciding anything.